News
Latest News
Scientists Advance Research Towards New Therapy for Medulloblastoma
NEW PUBLICATION Scientists Advance Research Towards New Therapy For Medulloblastoma Dr. Xi Huang Senior Scientist, Developmental & Stem Cell Biology [...]
Winners of the 2024 Proof of Principle Grant Competition
FUNDING ANNOUNCEMENT Winners of the 2024 Proof of Principle Grant Competition Christine Bear Senior Scientist, Molecular Medicine Comparison of SickKids [...]
SickKids Researcher Receives Commercialization Grant for Development of COPD Treatment
FUNDING ANNOUNCEMENT SickKids Researcher Receives Commercialization Grant for Development of COPD Treatment Dr. Christine Bear, Senior Scientist and Co-Director of the Cystic Fibrosis Centre at The [...]
Radiant Biotherapeutics Secures $35 Million to Advance Multabody™ Therapeutics
FUNDING ANNOUNCEMENT Radiant Biotherapeutics Secures $35 Million to Advance Multabody™ Therapeutics Industry Partnerships & Commercialization (IP&C) is excited to share that [...]
SickKids Scientist Dr. Adam Shlien Secures $6 Million To Advance Cancer Diagnostic Platform
SickKids Scientist Dr. Adam Shlien Secures $6 Million To Advance Cancer Diagnostic Platform Dr. Adam Shlien, a Senior Scientist in the [...]
Exploring Immune Responses in Type One Diabetes Onset
Exploring Immune Responses in Type One Diabetes Onset Research led by Dr. Jayne Danska, Senior Scientist in the Genetics and Genome [...]
Radiant Biotherapeutics Secures $2M Grant for Next-Gen HIV Biologics
Radiant Biotherapeutics Secures $2M Grant for Next-Gen HIV Biologics Industry Partnerships & Commercialization (IP&C) at The Hospital for Sick Children (SickKids) [...]
Accelerating Innovation: IP&C’s Eighth Annual Proof of Principle Competition Awards $300,000 to Outstanding SickKids’ Projects
Accelerating Innovation: IP&C's Eighth Annual Proof of Principle Competition Awards $300,000 to Outstanding SickKids' Projects From exploring innovative approaches for epilepsy [...]
A designer peptide against the EAG2–Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma
Breaking new ground in glioblastoma research: A designer peptide against the EAG2–Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma [...]
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo
A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo Researchers at The Hospital for Sick Children [...]














